Three CJEU decisions that answer some questions but pose many more.
- Published in:
- Journal of Intellectual Property Law & Practice, 2014, v. 9, n. 7, p. 599, doi. 10.1093/jiplp/jpu064
- By:
- Publication type:
- Article
Works matching DE "PATENT extensions"
Results: 31
1
2
Update: pioglitazone patent term extension.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 671
- Publication type:
- Article
3
Quantitative Analysis of the Role of Patents and Drug Approvals in Drug Lifecycle Management in Japan.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 157, doi. 10.1007/s40290-016-0141-y
- By:
- Publication type:
- Article
4
AN EMPIRICAL STUDY OF PATENT LITIGATION TIMING: COULD A PATENT TERM REDUCTION DECIMATE TROLLS WITHOUT HARMING INNOVATORS?
- Published in:
- University of Pennsylvania Law Review, 2013, v. 161, n. 5, p. 1309
- By:
- Publication type:
- Article
5
DID TRIPS SPUR INNOVATION? AN ANALYSIS OF PATENT DURATION AND INCENTIVES TO INNOVATE.
- Published in:
- University of Pennsylvania Law Review, 2009, v. 157, n. 6, p. 1613
- By:
- Publication type:
- Article
6
The log-linear relation between patent citations and patent value.
- Published in:
- Scientometrics, 2017, v. 110, n. 2, p. 879, doi. 10.1007/s11192-016-2208-7
- By:
- Publication type:
- Article
7
SOME PROBLEMS ASSOCIATED WITH THE APPLICATION OF COPYRIGHT LAW WITHIN THE MUSIC INDUSTRY.
- Published in:
- Interdisciplinary Management Research, 2009, v. 5, p. 831
- By:
- Publication type:
- Article
8
Ethics Issues Still Dog Pharmaceutical Industry.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
9
ESSAY: WHEN PATENTS AREN'T ENOUGH: WHY BIOLOGICS NECESSITATE DATA EXCLUSIVITY PROTECTION.
- Published in:
- 2014
- By:
- Publication type:
- Essay
10
HATCH-WAXMAN AND MEDICAL DEVICES.
- Published in:
- William Mitchell Law Review, 2014, v. 40, n. 4, p. 1407
- By:
- Publication type:
- Article
11
ADJUSTMENTS, EXTENSIONS, DISCLAIMERS, AND CONTINUATIONS: WHEN DO PATENT TERM ADJUSTMENTS MAKE SENSE?
- Published in:
- Capital University Law Review, 2013, v. 41, n. 3, p. 445
- By:
- Publication type:
- Article
12
Standing up for generic manufacturers: The increasing ability to challenge NDA patents.
- Published in:
- Journal of Generic Medicines, 2008, v. 6, n. 1, p. 73, doi. 10.1057/jgm.2008.22
- By:
- Publication type:
- Article
13
Fluvastatin and Atorvastatin: A comparison of patent protection (Part 1).
- Published in:
- Journal of Generic Medicines, 2007, v. 4, n. 4, p. 302, doi. 10.1057/palgrave.jgm.4950078
- By:
- Publication type:
- Article
14
Virtual patent extension by cannibalization.
- Published in:
- Southern Economic Journal, 1999, v. 66, n. 1, p. 117, doi. 10.2307/1060838
- By:
- Publication type:
- Article
15
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 12, doi. 10.1038/nrd3641
- By:
- Publication type:
- Article
16
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 96, doi. 10.1038/nrd3109
- By:
- Publication type:
- Article
17
Patent primer: Maximizing exclusivity for drug products.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 9, p. 709, doi. 10.1038/nrd1829
- By:
- Publication type:
- Article
18
USPTO proposes change.
- Published in:
- Journal of Intellectual Property Rights, 2010, v. 15, n. 3, p. 254
- Publication type:
- Article
19
AVANIR Pharmaceuticals awarded Zenvia patent.
- Published in:
- Journal of Intellectual Property Rights, 2010, v. 15, n. 2, p. 178
- Publication type:
- Article
20
Implications of Drug Price Competition and Patent Term Restoration Act (DPCPTRA) on Indian Pharma Industry.
- Published in:
- Journal of Intellectual Property Rights, 2009, v. 14, n. 6, p. 501
- By:
- Publication type:
- Article
21
TRIPS, WTO and IPR - Debate on Evergreening of Patents and IPA 2005.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
22
Intellectual property park set up.
- Published in:
- Journal of Intellectual Property Rights, 2005, v. 10, n. 3, p. 251
- Publication type:
- Article
23
Generic, proprietary drug manufacturers square off in patent extension debate.
- Published in:
- Formulary, 1996, v. 31, n. 6, p. 534
- By:
- Publication type:
- Article
24
Overview of the New Patent Law of the United States.
- Published in:
- Texas Intellectual Property Law Journal, 2013, v. 21, n. 1, p. 63
- By:
- Publication type:
- Article
25
So Long As You Live Under My Roof, You'll Live By ... Whose Rules?: Ending the Extraterritorial Application of Patent Law.
- Published in:
- Texas Intellectual Property Law Journal, 2009, v. 18, n. 1, p. 55
- By:
- Publication type:
- Article
26
Factors to evaluate a patent in addition to citations.
- Published in:
- Scientometrics, 2007, v. 71, n. 3, p. 509, doi. 10.1007/s11192-007-1698-8
- Publication type:
- Article
27
Patent Renewal Data.
- Published in:
- Brookings Papers on Economic Activity, 1989, p. 331, doi. 10.2307/2534724
- By:
- Publication type:
- Article
28
French call for 25 year drug patents.
- Published in:
- Chemistry & Industry, 2010, n. 3, p. 7
- By:
- Publication type:
- Article
29
PATENTS AND THE NEW TRUST PROBLEM.
- Published in:
- Law & Contemporary Problems, 1940, v. 7, n. 1, p. 74, doi. 10.2307/1189689
- By:
- Publication type:
- Article
30
Antimicrobial Resistance and the Ethics of Drug Development.
- Published in:
- American Journal of Public Health, 2006, v. 96, n. 11, p. 1910, doi. 10.2105/AJPH.2005.077214
- By:
- Publication type:
- Article
31
Hatch-Waxman changes debated.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 7, p. 710, doi. 10.1038/77264
- By:
- Publication type:
- Article